Compliance through reduction/cessation plus resident endorsement (combined) for Smoking

N/A

Recruiting

Led By Diana Hernández, PhD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upmeasured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will test two ways to reduce exposure to secondhand smoke in residential buildings. One targets all building residents, while the other targets smokers specifically, with the goal of reducing smoking and exposure to secondhand smoke.

Eligible Conditions

Smoking
Smoking Cessation

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in number of cigarettes smoked per day

Change in salivary cotinine

Change in secondhand smoke exposure

Secondary outcome measures

Change in number of cigarette butts

Change in number of hours of secondhand smoke exposure

Change in number of participants with secondhand smoke observations

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: Compliance through resident endorsementExperimental Treatment1 Intervention

Buildings assigned will be targeted for a series of 2 in-residence programs that involve community forums and the creative arts to garner resident endorsements of smoke-free living environments. Premised on resident engagement, this arm seeks to impact social and physical dimensions of the residential environment to achieve compliance. The sessions will: 1) inform residents of risks associated with smoking and secondhand smoke; 2) identify reasons to have a smoke-free home, 3) ask residents to sign a pledge on paper and/or virtually; 4) display smoke-free signage on doors and/or social media pages with an original hashtag (#Smokefree[building address]); and 5) refer residents to the Smoke-free NYCHA website for information on the policy and existing cessation resources.

Group II: Compliance through reduction/cessation plus resident endorsement (combined)Experimental Treatment2 Interventions

The combined intervention will be carried out in the buildings assigned to this RCT arm, which will provide in-residence programs based on the resident endorsement treatment and the smoking relocation/cessation treatment. Both will occur simultaneously with one geared toward all building residents (resident endorsement) and the other targeting smokers (smoking relocation/cessation) with the goal of reducing both personal smoking and secondhand smoke exposure.

Group III: Compliance through reduction (relocation and reduction of personal smoking) and cessationExperimental Treatment1 Intervention

Smokers will be referred by the survey team to peer educators from a community-based organization trained to provide peer to peer health education including tobacco cessation support. The peer educator will coordinate smoking cessation support, including serving as a liaison between participant and research team, providing information regarding the smoke-free policy and opportunities for relocation, and connecting participant to access to tobacco replacement therapy and/or physician support if deemed appropriate.

Group IV: Standard NYCHA approach (control)Active Control1 Intervention

Buildings and study participants assigned to this arm will be recruited and followed over a 12-month period to assess outcomes. No additional programs or services will be delivered to the buildings or residents assigned to this arm beyond standard programs that NYCHA may provide to support the smoke-free mandate. Field staff will document any policy-related signage, activities or information to which these participants are exposed.

Do I qualify?Apply below to find out

Find a site

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,381 Previous Clinical Trials

1,835,596 Total Patients Enrolled

4 Trials studying Smoking

12,318 Patients Enrolled for Smoking

National Cancer Institute (NCI)NIH

13,412 Previous Clinical Trials

41,238,554 Total Patients Enrolled

62 Trials studying Smoking

54,532 Patients Enrolled for Smoking

Diana Hernández, PhDPrincipal Investigator

Associate Professor

Media Library

Reduction (relocation and reduction of personal smoking) and cessation Clinical Trial Eligibility Overview. Trial Name: NCT05016505 — N/A

Smoking Research Study Groups: Standard NYCHA approach (control), Compliance through reduction/cessation plus resident endorsement (combined), Compliance through reduction (relocation and reduction of personal smoking) and cessation, Compliance through resident endorsement

Smoking Clinical Trial 2023: Reduction (relocation and reduction of personal smoking) and cessation Highlights & Side Effects. Trial Name: NCT05016505 — N/A

Reduction (relocation and reduction of personal smoking) and cessation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05016505 — N/A

Smoking Patient Testimony for trial: Trial Name: NCT05016505 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many study subjects are you working with in total?

"That is correct, the online information does show that the study is recruiting patients. The clinical trial was first advertised on February 3rd, and there have been recent updates on February 18th. A total of 512 patients are needed for the study, which is only enrolling at a single site."

Answered by AI

What are the researchers ultimately hoping to achieve with this trial?

"The key metric that this trial is measuring is change in salivary cotinine levels, which will be reported at the start of the study, 3 months in, and 12 months after the study has concluded. Additionally, the trial will also measure the number of successful quit attempts, the number of smokers, and the number of hours of secondhand smoke exposure."

Answered by AI